These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21088267)

  • 1. Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes.
    Cooper HL; Des Jarlais DC; Ross Z; Tempalski B; Bossak B; Friedman SR
    Am J Public Health; 2011 Jun; 101(6):1118-25. PubMed ID: 21088267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.
    Cooper H; Des Jarlais D; Ross Z; Tempalski B; Bossak BH; Friedman SR
    J Urban Health; 2012 Aug; 89(4):678-96. PubMed ID: 22585448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.
    Cooper HL; Bossak BH; Tempalski B; Friedman SR; Des Jarlais DC
    J Urban Health; 2009 Nov; 86(6):929-45. PubMed ID: 19911283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source.
    Quinn B; Chu D; Wenger L; Bluthenthal RN; Kral AH
    Int J Drug Policy; 2014 Sep; 25(5):905-10. PubMed ID: 24930425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
    Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.
    Heimer R; Clair S; Teng W; Grau LE; Khoshnood K; Singer M
    J Urban Health; 2002 Dec; 79(4):556-70. PubMed ID: 12468675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program.
    Tesoriero JM; Battles HB; Klein SJ; Kaufman E; Birkhead GS
    J Am Pharm Assoc (2003); 2009; 49(3):407-16. PubMed ID: 19443321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
    Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
    Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors.
    Cooper HL; Des Jarlais DC; Tempalski B; Bossak BH; Ross Z; Friedman SR
    Health Place; 2012 Mar; 18(2):218-28. PubMed ID: 22047790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program.
    Junge B; Vlahov D; Riley E; Huettner S; Brown M; Beilenson P
    J Am Pharm Assoc (Wash); 1999; 39(1):17-22. PubMed ID: 9990182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
    Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'It's just basically a box full of disease'-navigating sterile syringe scarcity in a rural New England state.
    Pollini RA; Paquette CE; Slocum S; LeMire D
    Addiction; 2021 Jan; 116(1):107-115. PubMed ID: 32415706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
    Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
    Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics.
    Fadanelli M; Cooper HLF; Freeman PR; Ballard AM; Ibragimov U; Young AM
    Harm Reduct J; 2022 Jan; 19(1):1. PubMed ID: 34996466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
    Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF
    Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
    Costenbader EC; Zule WA; Coomes CC
    Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.